NO20024059D0 - Fremgangsmåte for fremstilling av et oksazolyletanolderivat - Google Patents

Fremgangsmåte for fremstilling av et oksazolyletanolderivat

Info

Publication number
NO20024059D0
NO20024059D0 NO20024059A NO20024059A NO20024059D0 NO 20024059 D0 NO20024059 D0 NO 20024059D0 NO 20024059 A NO20024059 A NO 20024059A NO 20024059 A NO20024059 A NO 20024059A NO 20024059 D0 NO20024059 D0 NO 20024059D0
Authority
NO
Norway
Prior art keywords
preparation
oxazolylethanol derivative
oxazolylethanol
derivative
Prior art date
Application number
NO20024059A
Other languages
English (en)
Other versions
NO315197B1 (no
NO20024059L (no
Inventor
Koji Ando
Masanobu Suzuki
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20024059L publication Critical patent/NO20024059L/no
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of NO20024059D0 publication Critical patent/NO20024059D0/no
Publication of NO315197B1 publication Critical patent/NO315197B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20024059A 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et isoksasolylacetatderivat NO315197B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10409898 1998-03-30
PCT/JP1999/001434 WO1999050267A1 (fr) 1998-03-30 1999-03-19 Procede permettant de produire un compose a base d'iso-oxazolidinedione

Publications (3)

Publication Number Publication Date
NO20024059L NO20024059L (no) 1999-11-29
NO20024059D0 true NO20024059D0 (no) 2002-08-26
NO315197B1 NO315197B1 (no) 2003-07-28

Family

ID=14371652

Family Applications (4)

Application Number Title Priority Date Filing Date
NO19995851A NO314403B1 (no) 1998-03-30 1999-11-29 Fremstillingsfremgangsmåte for isoksasolidinedionforbindelse
NO20024058A NO315198B1 (no) 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO20024059A NO315197B1 (no) 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et isoksasolylacetatderivat
NO20024060A NO315199B1 (no) 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et oksazolyletanolderivat

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO19995851A NO314403B1 (no) 1998-03-30 1999-11-29 Fremstillingsfremgangsmåte for isoksasolidinedionforbindelse
NO20024058A NO315198B1 (no) 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et oksazolyletanolderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20024060A NO315199B1 (no) 1998-03-30 2002-08-26 Fremgangsmåte for fremstilling av et oksazolyletanolderivat

Country Status (25)

Country Link
US (4) US6248897B1 (no)
EP (3) EP1375499A1 (no)
JP (1) JP2000143596A (no)
KR (1) KR100321608B1 (no)
CN (4) CN1781915A (no)
AR (1) AR015745A1 (no)
AT (1) ATE258931T1 (no)
AU (1) AU738200B2 (no)
BR (1) BR9906312A (no)
CA (1) CA2291620C (no)
CO (1) CO5080736A1 (no)
CZ (1) CZ296507B6 (no)
DE (1) DE69914557T2 (no)
ES (1) ES2211053T3 (no)
HU (1) HUP0003273A3 (no)
IL (1) IL133146A (no)
NO (4) NO314403B1 (no)
NZ (1) NZ501896A (no)
PE (1) PE20000359A1 (no)
RU (1) RU2180663C2 (no)
SG (1) SG73627A1 (no)
SK (1) SK161499A3 (no)
TW (1) TWI224594B (no)
WO (1) WO1999050267A1 (no)
ZA (1) ZA997705B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69914557T2 (de) * 1998-03-30 2005-01-05 Japan Tobacco Inc. Verfahren zur herstellung einer isooxazolidindion-verbindung
US6768008B2 (en) 2000-04-24 2004-07-27 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6680387B2 (en) 2000-04-24 2004-01-20 Aryx Therapeutics Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
US6784199B2 (en) 2000-09-21 2004-08-31 Aryx Therapeutics Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
US6958355B2 (en) 2000-04-24 2005-10-25 Aryx Therapeutics, Inc. Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis
PL367325A1 (en) * 2001-04-16 2005-02-21 Tanabe Seiyaku Co, Ltd. Large conductance calcium-activated k channel opener
US6696474B2 (en) * 2002-04-03 2004-02-24 Warner Lambert Co. Llc. Antidiabetic agents
US6716842B2 (en) * 2002-04-05 2004-04-06 Warner-Lambert Company, Llc Antidiabetic agents
TWI343915B (en) * 2002-10-07 2011-06-21 Hoffmann La Roche Chirale ppar agonists
DE10328174A1 (de) * 2003-06-24 2005-01-13 Bayer Healthcare Ag Verfahren zur Herstellung von Aryloxazolylethylalkohol
EP1888571A2 (en) * 2005-03-22 2008-02-20 F. Hoffmann-Roche AG New salt and polymorphs of a dpp-iv inhibitor
EP1892231A1 (en) * 2006-08-21 2008-02-27 Bayer Schering Pharma Aktiengesellschaft A large scale method for the deoxofluorination of ketones

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1859667A (en) * 1930-05-14 1932-05-24 J K Gruner Lumber Company Jointed lumber
JPS58219169A (ja) 1982-06-15 1983-12-20 Takeda Chem Ind Ltd オキサゾ−ル酢酸誘導体
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
US5059720A (en) * 1990-01-31 1991-10-22 E. I. Du Pont De Nemours And Company Hydroxy containing fluorovinyl compounds and polymers thereof
ATE116971T1 (de) * 1990-08-23 1995-01-15 Pfizer Hypoglykämische hydroxyharnstoffderivate.
CA2075553A1 (en) * 1992-08-07 1994-02-08 George Zafir Insulated panel
US5678369A (en) * 1992-12-28 1997-10-21 Ig-Technical Research Inc. Refractory/heat insulating panels
JPH07188227A (ja) 1993-12-24 1995-07-25 Japan Tobacco Inc チアゾリジン誘導体及びオキサゾール誘導体
KR0164665B1 (ko) 1993-12-27 1999-01-15 미즈노 시게루 이소옥사졸리딘디온 유도체 및 그의 용도
TW403748B (en) * 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
IL120443A (en) * 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
US5768850A (en) * 1997-02-04 1998-06-23 Chen; Alen Method for erecting floor boards and a board assembly using the method
DE69914557T2 (de) * 1998-03-30 2005-01-05 Japan Tobacco Inc. Verfahren zur herstellung einer isooxazolidindion-verbindung
DE19851200C1 (de) * 1998-11-06 2000-03-30 Kronotex Gmbh Holz Und Kunstha Fußbodenpaneele
US8234204B2 (en) * 2000-11-13 2012-07-31 Goldman, Sachs & Co. Method and system for matching short trading positions with long trading positions

Also Published As

Publication number Publication date
CO5080736A1 (es) 2001-09-25
CA2291620C (en) 2003-10-07
EP1375499A8 (en) 2004-09-08
DE69914557D1 (de) 2004-03-11
NO20024058L (no) 1999-11-29
SG73627A1 (en) 2000-06-20
WO1999050267A1 (fr) 1999-10-07
US20010039352A1 (en) 2001-11-08
CA2291620A1 (en) 1999-10-07
AU738200B2 (en) 2001-09-13
CN1130361C (zh) 2003-12-10
CZ422499A3 (cs) 2000-04-12
NO315198B1 (no) 2003-07-28
DE69914557T2 (de) 2005-01-05
NO20024058D0 (no) 2002-08-26
CN1232511C (zh) 2005-12-21
AR015745A1 (es) 2001-05-16
HUP0003273A2 (hu) 2002-01-28
NZ501896A (en) 2000-11-24
EP0992503B1 (en) 2004-02-04
NO315197B1 (no) 2003-07-28
NO20024059L (no) 1999-11-29
KR20010013044A (ko) 2001-02-26
EP0992503A1 (en) 2000-04-12
US6699996B2 (en) 2004-03-02
AU2854899A (en) 1999-10-18
HUP0003273A3 (en) 2002-02-28
NO20024060L (no) 1999-11-29
NO315199B1 (no) 2003-07-28
EP1384722A8 (en) 2004-09-08
IL133146A (en) 2004-02-08
RU2180663C2 (ru) 2002-03-20
EP1384722A1 (en) 2004-01-28
PE20000359A1 (es) 2000-05-17
NO20024060D0 (no) 2002-08-26
US6444827B2 (en) 2002-09-03
CN1235887C (zh) 2006-01-11
ZA997705B (en) 2000-06-27
EP0992503A4 (en) 2001-11-07
US20050159466A1 (en) 2005-07-21
EP1375499A1 (en) 2004-01-02
US20020188133A1 (en) 2002-12-12
SK161499A3 (en) 2000-06-12
CN1495174A (zh) 2004-05-12
CN1781915A (zh) 2006-06-07
CZ296507B6 (cs) 2006-03-15
NO995851L (no) 1999-11-29
CN1511833A (zh) 2004-07-14
BR9906312A (pt) 2000-07-11
NO314403B1 (no) 2003-03-17
CN1272109A (zh) 2000-11-01
US6995271B2 (en) 2006-02-07
IL133146A0 (en) 2001-03-19
ATE258931T1 (de) 2004-02-15
US6248897B1 (en) 2001-06-19
ES2211053T3 (es) 2004-07-01
NO995851D0 (no) 1999-11-29
JP2000143596A (ja) 2000-05-23
TWI224594B (en) 2004-12-01
KR100321608B1 (ko) 2002-02-02

Similar Documents

Publication Publication Date Title
NO20011936L (no) Fremgangsmate for fremstilling av citalopram
NO976121L (no) FremgangsmÕte for fremstilling av karbonylforbindelser
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO20000189L (no) Fremgangsmõte for fremstilling av heparin
NO20024058L (no) Fremgangsmåte for fremstilling av et oksazolyletanolderivat
NO20002174L (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO20001387L (no) FremgangsmÕte for syntese av kinolinderivater
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO993912L (no) FremgangsmÕte for fremstilling av eprosartan
NO20000933L (no) Fremgangsmõte for fremstilling av polymer
NO993913L (no) FremgangsmÕte for fremstilling av eprosartan
NO20001777L (no) Fremgangsmate for fremstilling av substituerte 4-fenyl-4-cyanocykloheksankarboksylsyrer
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO20013044D0 (no) Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
EE04305B1 (et) Parendatud meetod farmatseutiliselt väärtuslike norbensomorfaaniderivaatide valmistamiseks
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees